Brown Brothers Harriman & CO Qiagen N.V. Transaction History

Brown Brothers Harriman & CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$41.91 - $50.48 $3,101 - $3,735	-74 Reduced 39.15%	115 $5,000
Q3 2022 Nov 10, 2022	BUY	$40.9 - $50.42 $3,026 - $3,731	74 Added 64.35%	189 $8,000
Q4 2021 Feb 14, 2022	SELL	$50.62 - $56.47 $65.9 Million - $73.5 Million	-1,301,864 Reduced 99.99%	115 $6,000
Q1 2021 May 13, 2021	BUY	$46.25 - $56.02 $50.9 Million - $61.7 Million	1,101,127 Added 548.23%	1,301,979 $63.4 Million
Q4 2020 Feb 16, 2021	BUY	$46.09 - $54.74 $9.26 Million - $11 Million	200,850 Added 0.0%	200,852 $10.6 Million

Q2 2020 Aug 13, 2020	SELL	$39.49 - $44.36 $1,263 - $1,419	-32 Reduced 94.12%	2 $0
Q1 2020 May 15, 2020	BUY	$33.17 - $41.6 $1,127 - $1,414	34 New	34 $1,000
Q1 2018 May 14, 2018	SELL	$31.01 - $34.72 $3,845 - $4,305	-124 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$30.68 - $35.37 $3,804 - $4,385	124	124 $4,000

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.16B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

Stay updated on Brown Brothers Harriman & CO with notifications on news.